This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
954 |
4. Check minimum number of events
Min. number of events
3
|
954 |
5. Include endpointsNone |
954 |
6. Filter based on genotype QC (FinnGen only) |
870 |
Control definitions (FinnGen only)
- Control exclude
- RX_L04AB
Extra metadata
- First used in FinnGen datafreeze
- DF4
Similar endpoints
↥List of similar endpoints to
Infliximab
based on the number of shared cases.
Similar with more cases:
- Tumor necrosis factor alpha inhibitors
- Biological medication for rheuma
- ILD medications: immunosuppressive drugs
- ILD medications
- Any reimbursement code in KELA
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 870 | 438 | 432 |
| Unadjusted period prevalence (%) | 0.18 | 0.16 | 0.20 |
| Median age at first event (years) | 44.93 | 44.85 | 45.01 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 902
- Matched controls
- 9020
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
156.2
307.7
196
16
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
194.0
307.7
737
203
A07EC02
ATC
mesalazine; oral, rectal
90.5
307.7
629
224
L04AB02
ATC
infliximab; parenteral
+∞
307.7
902
*
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
3102.5
307.7
699
10
UJF32
NOMESCO Finland
Coloscopy
17.8
307.7
598
898
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
45.6
307.7
227
66
L01BB02
ATC
mercaptopurine; oral
74.8
307.7
250
46
L04AX01
ATC
azathioprine; systemic
90.5
307.7
538
145
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
201.7
307.7
191
12
K51.5
ICD-10 Finland
Left sided colitis
62.3
307.7
430
130
A07EA06
ATC
budesonide; oral, local oral
78.3
307.7
478
128
K50.8
ICD-10 Finland
Other Crohn disease
68.3
307.7
245
49
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
53.8
307.7
383
122
UJF30
NOMESCO Finland
Ileoscopy through colon
25.3
307.7
488
401
ZX120
NOMESCO Finland
Intravenous
23.6
307.7
396
289
K50.9
ICD-10 Finland
Crohn disease, unspecified
47.9
307.6
184
48
K50.0
ICD-10 Finland
Crohn disease of small intestine
40.4
298.2
187
58
K50.1
ICD-10 Finland
Crohn disease of large intestine
55.3
296.4
171
38
A07EA02
ATC
hydrocortisone; rectal
35.8
296.2
193
68
H02AB06
ATC
prednisolone; systemic
19.2
286.0
798
2575
A07EC01
ATC
sulfasalazine; oral, rectal
16.5
280.7
269
226
L04AX03
ATC
methotrexate; systemic
13.8
273.9
302
317
K51.8
ICD-10 Finland
Other ulcerative colitis
40.3
273.7
171
52
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
9.1
249.5
478
993
4AA12, ,
NOMESCO Finland
91.2
213.0
112
14
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
33.2
206.8
136
48
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
10.5
193.2
250
319
K51
ICD-10 Finland
Ulcerative colitis
34.9
192.2
124
41
L04AB04
ATC
adalimumab; parenteral
487.9
167.5
162
*
TPH04
NOMESCO Finland
Cathetrisation of vein
6.4
163.3
391
958
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
29.0
160.9
110
43
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
10.8
153.9
185
211
L01BA01
ATC
methotrexate; systemic
23.5
145.7
108
52
UJF92
NOMESCO Finland
Capsular endoscopy
18.6
132.5
109
66
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
35.5
132.0
84
26
WVA20
NOMESCO Finland
Medicine administration
14.6
125.3
118
92
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.0
124.9
557
2200
4AB02, ,
NOMESCO Finland
163.9
122.7
127
9
D94
ICPC
Chronic enteritis/ulcerative colitis
38.9
121.0
75
21
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
33.1
117.1
76
25
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
8.6
107.8
151
206
M45
ICD-10 Finland
Ankylosing spondylitis
15.4
102.9
93
67
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
35.6
99.3
63
19
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
9.5
93.4
118
141
H02AB07
ATC
prednisone; oral
5.7
92.3
204
443
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
7.7
82.5
124
182
L88
ICPC
Rheumatoid/seropositive arthritis
11.6
81.4
87
82
L04AC05
ATC
ustekinumab; parenteral
46.0
80.9
48
11
L04AB06
ATC
golimumab; parenteral
+∞
75.1
71
*
L04AD01
ATC
ciclosporin; systemic
13.9
75.0
71
55
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.7
71.7
317
1151
L04AA13
ATC
[U] leflunomide
23.0
68.0
50
23
L04AB01
ATC
etanercept; parenteral
347.4
64.3
64
*
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
18.3
57.9
47
27
J01MA02
ATC
ciprofloxacin; systemic
3.0
56.0
388
1802
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
8.6
54.4
72
90
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
13.9
52.3
49
37
P01AB01
ATC
metronidazole; oral, rectal
2.9
51.9
443
2278
WZC30
NOMESCO Finland
Teaching
3.5
49.5
206
701
A02BC02
ATC
pantoprazole; systemic
3.0
49.1
643
4089
L04AA01
ATC
[U] ciclosporin
19.7
45.9
36
19
WW200
NOMESCO Finland
Immunization
7.1
43.4
68
103
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
64.6
42.6
49
8
K50
ICD-10 Finland
Crohn disease [regional enteritis]
72.2
42.5
48
7
L04AB05
ATC
certolizumab pegol; parenteral
+∞
42.0
40
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
14.8
41.0
37
26
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
10.1
40.7
47
49
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
5.1
40.3
90
192
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
8.7
40.2
52
63
P01BA02
ATC
hydroxychloroquine; oral
4.9
39.9
94
210
K60.3
ICD-10 Finland
Anal fistula
8.3
38.7
52
66
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
10.2
37.7
43
44
298, ,
Kela drug reimbursment
62.8
36.5
42
7
WX002
NOMESCO Finland
Sedation and analgesia
3.1
36.4
183
689
JHA00
NOMESCO Finland
Anal or perianal incision
8.6
36.2
47
57
3029
Kela drug reimbursment
Upadacitinib
43.9
34.3
42
10
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
9.9
33.5
39
41
M13.9
ICD-10 Finland
Arthritis, unspecified
4.0
32.6
101
278
L04AF03
ATC
upadacitinib; oral
45.2
32.1
39
9
C10AC01
ATC
colestyramine; oral
6.8
31.4
50
77
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
114.1
30.9
33
*
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
6.9
30.5
48
73
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
68.3
29.1
33
5
K61.0
ICD-10 Finland
Anal abscess
6.6
28.9
47
74
253, ,
Kela drug reimbursment
66.2
28.1
32
5
3042, ,
Kela drug reimbursment
66.2
28.1
32
5
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
5.0
27.2
61
130
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.7
27.0
64
143
A06AC01
ATC
ispaghula (psylla seeds); oral
2.5
26.9
218
1035
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.2
25.7
54
109
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.9
25.0
78
215
L04AC10
ATC
secukinumab; parenteral
57.7
24.1
28
5
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
20.2
23.6
35
18
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
23.6
108
381
N02AX02
ATC
tramadol; systemic, rectal
2.1
23.3
358
2185
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.2
22.8
242
1280
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.0
21.4
33
49
NH3EA
NOMESCO Finland
Feet X-ray examination with load
7.4
21.3
31
43
WZA10
NOMESCO Finland
Extensive medical or dental certificate
7.4
20.4
30
42
L04AG05
ATC
vedolizumab; parenteral
49.2
20.2
24
5
JF1AD
NOMESCO Finland
Small bowel CT
25.2
19.6
27
11
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
19.4
418
2819
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
18.7
19.2
29
16
L04AA44
ATC
[U] upadacitinib
56.3
19.0
22
*
L40.5
ICD-10 Finland
Arthropathic psoriasis
7.2
18.7
28
40
256, ,
Kela drug reimbursment
102.2
18.6
20
*
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.5
18.4
64
190
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.6
18.1
112
463
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
18.0
426
2937
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
97.0
17.6
19
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
17.3
369
2453
L04AA29
ATC
[U] tofacitinib
51.0
17.0
20
*
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
5.8
16.9
31
55
JF1BD
NOMESCO Finland
Very extensive small bowel CT
35.8
16.7
21
6
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.9
16.7
82
300
M01AH01
ATC
celecoxib; oral
2.4
16.6
123
552
L04AA24
ATC
abatacept; parenteral
173.1
16.5
17
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
16.3
231
1340
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
16.2
85
322
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.8
16.2
319
2060
ZX112
NOMESCO Finland
Subcutaneous
6.9
16.2
25
37
ZX140
NOMESCO Finland
Intra articular
21.4
16.0
23
11
D06BX01
ATC
metronidazole; topical
2.5
15.6
102
432
S01BA01
ATC
dexamethasone; ophthalmic
4.5
15.6
38
87
J05AB11
ATC
valaciclovir; oral
2.2
15.5
142
699
3005
Kela drug reimbursment
Tofacitinib
38.8
15.4
19
5
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
15.3
123
573
JHD30
NOMESCO Finland
Incomplete incision of fistula-in-ano
29.2
15.2
20
7
E0000UV, ,
ATC
1.8
15.2
394
2751
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
14.8
119
553
N02BE01
ATC
paracetamol; systemic, rectal
2.2
14.8
774
6645
JHD20
NOMESCO Finland
Incision of fistula-in-ano
6.5
14.6
24
38
L04AA11
ATC
[U] etanercept
81.5
14.6
16
*
M01CB01
ATC
sodium aurothiomalate; parenteral
36.7
14.5
18
5
D07XC01
ATC
betamethasone; topical
2.4
14.4
106
474
3AC01, ,
NOMESCO Finland
10.7
14.3
27
26
M25.5
ICD-10 Finland
Pain in joint
1.8
14.1
313
2079
B02.9
ICD-10 Finland
Zoster without complication
3.2
14.0
57
187
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
3.8
13.9
42
113
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.8
13.9
321
2153
JHD33
NOMESCO Finland
Completing incision of fistula-in-ano
24.2
13.8
19
8
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.2
13.7
28
55
L04AA17
ATC
[U] adalimumab
+∞
13.6
13
*
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
13.6
13
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
13.6
58
196
D07AC01
ATC
betamethasone; topical
1.8
13.4
310
2077
H02AB04
ATC
methylprednisolone; systemic
2.2
13.3
116
557
S01BA04
ATC
prednisolone; ophthalmic
6.4
13.3
22
35
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
5.8
13.3
24
42
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.2
13.2
27
53
L04AC13
ATC
ixekizumab; parenteral
40.7
13.2
16
*
D07AC13
ATC
mometasone; topical
1.8
13.0
245
1543
A07EA01
ATC
prednisolone; oral, rectal
19.4
12.9
19
10
JFB20
NOMESCO Finland
Ileocaecal resection
22.9
12.9
18
8
H20.1
ICD-10 Finland
Chronic iridocyclitis
10.7
12.8
24
23
A07EC03
ATC
olsalazine; oral
70.9
12.6
14
*
L04AC07
ATC
tocilizumab; parenteral
70.9
12.6
14
*
291
Kela drug reimbursment
Tofacitinib
70.9
12.6
14
*
J01DB01
ATC
cefalexin; oral
2.0
12.6
754
6515
K92.1
ICD-10 Finland
Melaena
3.6
12.5
42
122
M07.3
ICD-10 Finland
Other psoriatic arthropathies
13.4
12.5
21
16
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.1
12.5
54
184
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
12.2
282
1878
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
38.1
12.2
15
*
A07AA09
ATC
vancomycin; oral
10.2
12.0
23
23
JFB21
NOMESCO Finland
Laparoscopic ileocaecal resection
65.8
11.6
13
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
10.2
11.5
22
22
JFA38
NOMESCO Finland
Endoscopic dilatation of small intestine
121.5
11.4
12
*
4AB0M, ,
NOMESCO Finland
121.5
11.4
12
*
M08.1
ICD-10 Finland
Juvenile ankylosing spondylitis
35.5
11.3
14
*
L40.8
ICD-10 Finland
Other psoriasis
20.3
11.2
16
8
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
14.1
11.0
18
13
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.0
11.0
130
701
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.1
10.9
46
154
D07AD01
ATC
clobetasol; topical
2.0
10.9
136
746
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
10.8
65
264
C05AA08
ATC
fluocortolone; rectal, topical
2.2
10.7
98
479
5551A
ICD-9 Finland
Regional enteritis, Large intestine
+∞
10.4
10
*
B01AB05
ATC
enoxaparin; parenteral
1.8
10.4
193
1201
L04AA33
ATC
[U] vedolizumab
40.5
10.0
12
*
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
20.3
9.8
14
7
H15.1
ICD-10 Finland
Episcleritis
4.8
9.8
22
47
D11
ICPC
Diarrhoea
1.9
9.7
145
845
H02AB09
ATC
hydrocortisone; systemic
3.8
9.7
29
78
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
9.5
345
2543
A02BC03
ATC
lansoprazole; oral
1.7
9.5
180
1125
4AB0X, ,
NOMESCO Finland
+∞
9.4
9
*
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
5.0
9.3
20
41
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
9.3
327
2393
R50.9
ICD-10 Finland
Fever, unspecified
1.8
9.2
143
841
SPAT1131
SPAT
Colonoscopy
4.3
9.2
23
54
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
5.1
9.1
19
38
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
24.3
8.9
12
5
Z3231
NOMESCO Finland
Registered nurse
1.7
8.8
211
1403
D05AX52
ATC
calcipotriol, combinations; topical
2.7
8.7
48
187
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
9.1
8.6
17
19
M06
ICD-10 Finland
Other rheumatoid arthritis
27.8
8.5
11
*
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
8.5
249
1739
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
7.4
8.5
19
26
A06AC51
ATC
ispaghula, combinations; oral
2.9
8.4
39
139
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
+∞
8.3
8
*
A05AA02
ATC
ursodeoxycholic acid; oral
3.7
8.3
26
72
NG1DA
NOMESCO Finland
X-ray of knees
4.8
8.1
18
38
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
8.1
179
1162
UJG02
NOMESCO Finland
Proctoscopy
4.3
8.0
20
47
TNG10
NOMESCO Finland
Puncture of knee
7.9
7.9
17
22
K59.1
ICD-10 Finland
Functional diarrhoea
2.4
7.8
53
229
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
45.4
7.7
9
*
K51.4
ICD-10 Finland
Inflammatory polyps
45.4
7.7
9
*
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
6.0
7.7
20
34
B03BA03
ATC
hydroxocobalamin; parenteral
3.4
7.7
27
81
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
7.6
69
336
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
18.5
7.6
11
6
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
25.2
7.6
10
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
7.5
85
450
B02
ICD-10 Finland
Zoster [herpes zoster]
2.6
7.5
42
165
L71.8
ICD-10 Finland
Other rosacea
4.3
7.5
19
45
E000001, ,
ATC
1.6
7.4
177
1171
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
13.5
7.4
12
9
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
13.5
7.4
12
9
JFB00
NOMESCO Finland
Partial resection of small intestine
6.9
7.3
17
25
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
+∞
7.3
7
*
3048, ,
Kela drug reimbursment
+∞
7.3
7
*
255, ,
Kela drug reimbursment
+∞
7.3
7
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.5
7.3
43
174
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
6.3
7.3
18
29
ZXE00
NOMESCO Finland
One hour or less
1.5
7.2
293
2185
L88
ICD-10 Finland
Pyoderma gangrenosum
30.3
7.2
9
*
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.8
7.1
21
56
L04AK01
ATC
leflunomide; oral
12.1
7.1
12
10
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
8.9
7.1
14
16
K61.1
ICD-10 Finland
Rectal abscess
10.1
7.0
13
13
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
7.0
96
543
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.4
7.0
17
39
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.3
6.9
25
77
WW200, ,
SPAT
1.6
6.9
209
1463
A02BC05
ATC
esomeprazole; systemic
1.5
6.8
282
2107
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
11.0
6.8
12
11
JH1CM
NOMESCO Finland
Perianal extensive MRI with 3 Tesla magnet
40.4
6.8
8
*
L04AC21
ATC
bimekizumab; systemic
40.4
6.8
8
*
M46.8
ICD-10 Finland
Other specified inflammatory spondylopathies
40.4
6.8
8
*
L04AC14
ATC
sarilumab; systemic
40.4
6.8
8
*
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
16.8
6.8
10
6
D16
ICPC
Rectal bleeding
3.3
6.7
25
78
J01MA12
ATC
levofloxacin; systemic
1.8
6.7
107
633
J01FF01
ATC
clindamycin; systemic
1.6
6.7
203
1420
K83.0
ICD-10 Finland
Cholangitis
6.0
6.6
17
29
R2110
NOMESCO Finland
Giving the first information
2.2
6.6
56
267
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
6.5
111
670
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
70.3
6.4
7
*
WX723
NOMESCO Finland
CPAP therapy
2.4
6.4
43
185
R06AE07
ATC
cetirizine; oral
1.4
6.4
396
3188
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
6.6
6.4
15
23
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
11.1
6.3
11
10
R01AD12
ATC
fluticasone furoate; nasal
1.5
6.3
309
2382
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
18.2
6.3
9
5
M09.1*K50.9
ICD-10 Finland
Juvenile arthritis in Crohn's disease [regional enteritis]
+∞
6.3
6
*
EB4VA, ,
NOMESCO Finland
1.5
6.2
184
1280
M01AC06
ATC
meloxicam; systemic, rectal
1.5
6.1
221
1600
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
7.7
6.1
13
17
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
6.1
72
387
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
6.1
49
228
L30.0
ICD-10 Finland
Nummular dermatitis
2.6
6.1
33
128
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
780
1196
41.82
307.65
11.8
2.4
217.27
101.70
ug/g
12.91
771
963
614
16
1199.75
307.65
3.2
3.0
80.50
90.14
au/ml
—
56
7
448
410
20.72
307.65
2.1
1.5
—
—
—
0
0
576
233
66.63
307.65
1.7
1.6
0.82
0.03
iu/ml
1.01
113
31
897
3788
248.39
302.55
29.4
6.2
0.58
0.55
e9/l
4.48
872
3305
897
3790
248.16
302.37
29.5
6.2
0.04
0.04
e9/l
3.91
872
3303
897
3916
234.36
290.97
29.7
6.2
2.10
1.99
e9/l
2.17
873
3497
897
3937
232.14
289.10
29.8
6.6
0.18
0.19
e9/l
1.58
872
3484
791
2607
17.53
274.39
12.7
5.0
37.67
37.53
g/l
0.39
785
2471
894
4196
128.42
260.48
30.2
9.2
3.56
3.97
e9/l
12.08
870
3639
810
3143
16.46
225.48
4.9
2.5
74.19
72.14
nmol/l
1.46
802
2956
579
1610
8.25
223.41
4.1
2.1
2.39
2.60
mg/l
1.99
553
1401
854
3549
27.43
221.98
27.6
6.1
53.12
56.07
%
15.79
854
3422
853
3616
26.02
214.61
28.6
6.2
32.94
29.59
%
21.84
853
3466
187
192
12.03
168.17
1.7
7.1
338.64
396.10
iu/ml
0.10
11
20
166
207
9.60
128.22
1.4
1.2
—
—
—
0
0
688
3343
5.46
114.61
31.0
9.2
0.00
0.00
e9/l
0.31
642
2722
155
244
7.46
97.32
1.2
1.3
246.69
230.17
u/ml
0.26
88
141
842
5255
10.05
93.64
13.5
3.6
11.04
8.08
mm/h
9.77
825
4983
280
834
4.42
85.79
2.1
2.4
23.80
24.87
%
0.56
273
785
119
174
7.73
79.36
1.1
1.1
—
—
—
0
0
286
931
4.03
76.61
2.2
2.4
2.43
2.42
g/l
0.08
276
868
298
999
3.96
76.53
2.2
2.4
14.32
14.86
umol/l
0.50
290
936
897
7170
46.28
75.43
28.7
10.0
97.55
95.20
ml/min/173m2
3.79
869
6432
680
3971
3.89
71.42
4.5
3.1
83.48
93.66
ug/l
1.32
670
3800
616
3437
3.50
68.23
5.9
6.3
10.69
11.11
umol/l
0.47
597
3287
166
416
4.66
62.12
1.3
1.5
—
—
—
0
0
902
7656
+∞
60.78
40.7
11.2
10.67
21.44
mg/l
66.67
871
6019
199
628
3.78
54.00
2.3
2.8
11.87
10.46
g/l
6.39
194
578
406
2086
2.72
46.35
5.6
2.7
59.38
59.61
u/l
0.02
386
1967
64
86
7.93
45.48
1.6
1.3
—
—
—
0
0
64
86
7.93
45.48
1.6
1.3
—
—
—
0
0
64
86
7.93
45.48
1.6
1.3
—
—
—
0
0
484
2755
2.63
44.29
4.4
3.5
30.00
31.84
u/l
0.85
459
2624
78
136
6.18
43.52
1.2
1.2
—
—
—
0
0
37
24
16.03
42.77
1.9
1.3
42.75
36.53
%
0.29
27
17
60
82
7.77
41.99
1.5
1.3
—
—
—
0
0
120
315
4.24
41.62
1.8
2.0
4.59
6.38
iu/ml
0.44
28
72
60
83
7.67
41.54
1.5
1.3
—
—
—
0
0
60
83
7.67
41.54
1.5
1.3
—
—
—
0
0
127
352
4.04
40.89
1.8
1.8
—
—
—
0
0
376
1967
2.56
39.99
5.7
3.0
0.00
0.01
estimate
1.08
207
710
902
8116
+∞
38.99
39.8
12.9
73.27
73.36
umol/l
0.05
902
8029
902
8136
+∞
38.20
41.3
9.4
28.44
29.22
u/l
0.81
902
7967
65
113
6.12
36.30
1.8
1.4
—
—
—
0
0
568
3799
2.34
32.42
5.2
3.0
0.00
0.00
estimate
0.50
210
748
571
3849
2.32
31.68
5.2
3.1
0.02
0.01
estimate
0.05
199
695
569
3843
2.30
31.23
5.2
3.0
0.00
8.47
estimate
1.33
209
741
345
1927
2.28
29.71
1.6
1.5
2.54
2.23
g/l
3.86
267
1285
232
1117
2.45
27.86
2.5
1.5
406.07
46317277.91
pmol/l
1.75
218
991
37
13
29.61
27.78
1.0
1.0
—
—
—
0
0
67
152
4.68
27.78
2.3
2.8
1.51
2.27
index
0.58
39
83
36
45
8.29
27.03
1.9
1.5
51.58
56.30
%
0.23
26
33
39
58
6.98
25.22
1.1
1.1
1237.21
1343.24
miu/ml
0.22
39
58
52
107
5.10
24.16
2.1
1.4
9100.76
13461.08
e6/l
0.34
42
77
46
91
5.27
22.33
1.3
1.5
—
—
—
0
0
41
73
5.84
22.27
1.2
1.2
—
—
—
0
0
41
74
5.76
21.96
1.2
1.2
—
—
—
0
0
438
2922
1.97
21.71
4.2
7.2
1.22
1.21
mmol/l
2.90
388
2567
45
90
5.21
21.58
1.2
1.5
—
—
—
0
0
440
2963
1.95
20.99
5.3
2.8
0.00
0.02
estimate
1.56
180
642
388
2568
1.90
18.92
3.5
6.8
1.22
1.21
mmol/l
1.84
371
2399
844
7362
3.28
18.66
13.7
12.0
139.35
139.67
mmol/l
4.84
835
7206
233
1302
2.06
18.55
2.9
2.4
4.62
7.01
e6/l
1.98
228
1176
354
2293
1.90
18.30
4.8
2.5
0.00
0.02
estimate
1.74
180
615
844
7383
3.23
18.13
13.8
12.1
3.88
3.93
mmol/l
9.36
833
7204
345
2223
1.89
18.07
1.4
1.4
1.21
1.55
u/ml
0.33
114
654
384
2561
1.87
18.06
2.1
1.8
91.68
99.45
pmol/l
3.03
281
1410
232
1317
2.03
17.57
1.4
1.3
12.07
6.23
u/ml
0.62
99
542
36
75
4.96
16.49
1.4
1.3
155.00
322.73
titre
0.56
14
11
794
6829
2.36
16.05
40.3
14.0
13.53
13.24
%
11.18
794
6753
275
1710
1.87
15.65
3.3
4.1
96.27
94.43
%
0.82
269
1673
248
1498
1.90
15.41
1.7
1.5
20.38
19.86
nmol/l
0.23
236
1328
902
8652
+∞
15.32
50.5
17.5
41.74
42.65
%
0.66
902
8583
902
8650
+∞
15.30
50.3
17.0
91.59
89.76
fl
29.42
902
8588
83
321
2.75
15.22
1.2
1.2
0.14
1.67
u/ml
—
5
18
902
8658
+∞
14.92
50.7
17.2
139.21
140.12
g/l
1.54
902
8592
305
1995
1.80
14.54
3.3
2.9
26.17
47.06
e6/l
1.21
259
1453
239
1452
1.88
14.46
1.4
1.3
20.66
20.02
iu/ml
0.04
59
412
269
1723
1.80
13.60
3.1
2.8
0.61
0.33
e6/l
0.51
219
1191
23
39
6.03
13.11
1.2
1.3
—
—
—
0
0
138
727
2.06
12.50
2.1
1.6
1141.51
1138.52
nmol/l
0.01
102
573
131
690
2.05
11.84
2.4
2.6
35.25
102.09
u/l
0.48
124
595
59
218
2.83
11.79
1.3
1.1
—
—
—
0
0
497
3868
1.63
11.63
3.2
5.2
6.18
6.42
mmol/l
2.39
477
3588
58
215
2.81
11.52
1.2
1.5
—
18.12
—
0
5
34
91
3.84
11.38
1.1
1.2
—
23.40
—
0
5
58
219
2.76
11.13
1.2
1.1
—
—
—
0
0
54
207
2.71
10.09
1.2
1.5
162.80
146.21
au/ml
—
10
59
142
816
1.88
9.90
2.1
3.1
5.57
7.36
umol/l
1.16
124
712
56
221
2.64
9.89
1.2
1.2
5.88
10.84
u/ml
—
5
34
42
148
2.93
9.17
2.2
1.6
—
—
—
0
0
29
85
3.49
8.55
1.1
1.1
262.55
281.91
mg/l
0.71
29
80
19
26
7.44
8.47
1.2
1.3
—
—
—
0
0
19
26
7.44
8.47
1.2
1.3
—
—
—
0
0
34
119
2.93
7.55
1.3
1.3
1080.00
231.43
titre
—
6
7
16
21
7.74
7.41
1.1
1.2
—
—
—
0
0
16
21
7.74
7.41
1.1
1.2
—
—
—
0
0
18
30
6.10
7.10
1.1
1.2
—
—
—
0
0
527
4430
1.46
6.93
4.7
3.7
15.43
1193.57
e6/l
—
7
53
13
14
9.40
6.80
1.3
2.0
3.54
2.43
%
0.33
13
14
41
173
2.44
6.38
1.5
1.9
0.51
1.27
ug/l
1.29
36
160
94
545
1.81
6.33
1.5
1.4
—
—
—
0
0
139
904
1.64
6.18
1.5
1.9
—
—
—
0
0
17
36
4.79
5.63
1.3
1.2
50.29
96.38
u/l
2.30
17
36
17
36
4.79
5.63
1.3
1.2
10.12
27.69
u/l
1.17
17
36
26
93
2.85
5.61
1.2
1.3
—
—
—
0
0
284
2207
1.42
5.36
3.0
2.7
19.73
68.14
ng/l
0.74
138
1137
94
574
1.71
5.31
2.5
2.7
—
—
—
0
0
44
209
2.16
5.25
2.1
1.9
—
—
—
0
0
16
44
3.68
5.22
1.0
1.1
217.88
160.85
iu/ml
0.49
16
44
19
59
3.27
5.19
1.2
1.1
—
60.50
—
0
6
75
432
1.80
5.18
2.5
2.3
0.12
0.16
e6/l
0.37
70
405
221
1653
1.45
5.11
2.2
2.5
325.84
334.92
umol/l
0.82
210
1530
308
2450
1.39
5.02
1.8
1.7
—
—
—
0
0
25
94
2.71
4.94
1.3
1.7
—
—
—
0
0
229
1746
1.42
4.73
5.3
3.0
1.02
1.02
kg/l
0.30
163
1094
28
116
2.46
4.59
1.3
1.7
—
—
—
0
0
11
19
5.85
4.45
1.0
1.4
—
—
—
0
0
40
198
2.07
4.34
2.2
1.8
—
—
—
0
0
34
160
2.17
4.20
1.4
2.6
—
—
—
0
0
20
75
2.70
4.01
1.1
1.1
—
—
—
0
0
21
81
2.63
3.99
1.0
1.1
—
—
—
0
0
19
70
2.75
3.94
1.1
1.1
—
—
—
0
0
78
496
1.63
3.82
3.1
2.4
78.44
80.22
ml/min/173m2
0.17
32
204
707
6535
1.38
3.81
3.6
3.7
—
—
—
0
0
256
2051
1.35
3.81
2.4
3.1
2.34
2.36
mmol/l
1.13
247
1905
19
72
2.67
3.75
1.1
1.1
—
—
—
0
0
19
72
2.67
3.75
1.1
1.1
—
—
—
0
0
21
84
2.54
3.73
1.0
1.2
—
—
—
0
0
8
12
6.71
3.68
1.3
1.3
—
—
—
0
0
212
1660
1.36
3.65
1.6
1.9
0.79
0.97
mg/l
0.46
143
1195
13
37
3.55
3.41
1.7
4.5
1.00
0.89
index
0.23
13
37
18
70
2.60
3.40
1.1
1.1
—
—
—
0
0
14
49
2.89
3.20
2.1
1.9
—
—
—
0
0
39
215
1.85
3.18
1.6
2.2
1.54
1.34
g/l
0.53
33
195
48
286
1.72
3.04
1.7
1.6
—
—
—
0
0
13
46
2.85
2.92
1.5
1.4
34.08
33.52
pg
0.19
13
46
8
17
4.74
2.92
1.1
1.1
73.75
103.35
%
—
8
17
32
171
1.90
2.89
1.3
1.7
—
—
—
0
0
10
27
3.73
2.88
1.7
3.0
0.80
1.13
%
—
10
27
13
317
0.40
2.88
3.8
15.1
16.56
16.54
%
0.01
13
305
151
1168
1.35
2.78
2.3
3.2
279.22
769.58
ng/l
2.56
116
924
29
152
1.94
2.78
1.3
1.7
—
—
—
0
0
5
6
8.37
2.75
1.0
1.3
—
—
—
0
0
81
564
1.48
2.71
2.4
2.4
13.89
15.76
au/ml
0.25
11
79
12
40
3.03
2.70
1.1
1.1
—
—
—
0
0
14
55
2.57
2.62
1.0
2.1
—
—
—
0
0
78
548
1.46
2.51
2.1
4.2
2.50
1.66
mmol/l
2.21
68
483
23
116
2.01
2.47
2.8
2.6
6.33
6.49
pmol/l
0.06
23
116
49
319
1.57
2.27
1.4
1.4
—
—
—
0
0
367
3244
1.22
2.26
2.5
2.8
—
—
estimate
—
0
0
36
218
1.68
2.22
2.1
2.7
10.34
10.64
mg/l
0.12
36
204
20
102
1.98
2.11
1.4
1.9
—
—
—
0
0
12
49
2.47
2.11
2.7
1.5
18.67
18.09
mg/l
—
6
25
32
191
1.70
2.09
1.3
1.4
313.39
302.66
ug/g
0.13
18
102
7
20
3.52
2.06
1.1
1.3
—
—
—
0
0
134
1066
1.30
2.05
2.6
2.6
0.76
0.88
e6/l
0.21
71
495
77
563
1.40
2.04
1.0
1.1
—
—
—
0
0
112
1421
0.76
2.02
1.7
1.8
3.37
3.64
ratio
1.90
88
1072
74
997
0.72
2.00
2.5
2.3
0.56
0.65
ug/l
0.89
39
428
63
448
1.44
1.95
1.3
1.5
8.46
7.28
u/l
0.26
51
367
72
525
1.40
1.94
1.6
1.8
0.23
0.31
mg/l
0.84
39
263
125
999
1.29
1.86
2.6
2.7
2.84
2.99
e6/l
0.08
65
430
29
175
1.68
1.84
1.3
1.8
—
—
—
0
0
69
506
1.39
1.82
1.3
1.3
252.25
226.87
miu/ml
0.18
30
249
84
640
1.34
1.75
1.4
1.9
—
—
—
0
0
17
88
1.95
1.75
1.4
1.6
—
—
—
0
0
8
30
2.68
1.72
1.0
1.0
—
—
—
0
0
40
268
1.52
1.69
1.1
1.1
22.25
5.21
eliau/ml
—
6
51
125
1018
1.26
1.61
1.8
2.5
2.41
2.42
mmol/l
0.06
118
910
12
56
2.16
1.61
1.0
1.1
—
—
—
0
0
680
7095
0.83
1.59
3.5
3.6
1.32
1.29
mmol/l
0.44
665
6773
10
43
2.34
1.59
1.6
1.6
—
—
—
0
0
7
26
2.71
1.58
1.4
1.5
—
—
—
0
0
7
26
2.71
1.58
1.4
1.5
—
—
—
0
0
7
26
2.71
1.58
1.4
1.5
—
—
—
0
0
7
26
2.71
1.58
1.4
1.5
—
—
—
0
0
26
406
0.63
1.54
1.2
1.9
8.75
3.70
mg/l
0.35
20
280
84
654
1.31
1.54
1.4
1.8
—
—
—
0
0
29
439
0.65
1.50
1.6
1.5
1.12
1.20
ratio
0.25
20
281
29
439
0.65
1.50
1.6
1.5
0.95
0.95
ratio
0.03
20
281
29
439
0.65
1.50
1.6
1.5
1.14
1.22
ratio
0.19
20
282
18
101
1.80
1.49
1.2
1.9
—
—
—
0
0
87
1089
0.78
1.44
1.6
1.6
3.24
3.52
mmol/l
1.53
64
743
191
1651
1.20
1.41
2.0
2.3
—
—
—
0
0
106
1288
0.80
1.38
3.0
2.9
24.99
21.70
%
0.75
40
373
29
429
0.67
1.36
1.6
1.5
—
—
—
0
0
5
17
2.95
1.36
1.2
2.2
2.13
1.52
ratio
—
5
17
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
20
121
1.67
1.31
1.1
1.9
0.00
0.00
g/l
-0.00
15
108
18
106
1.71
1.30
1.3
1.6
—
—
—
0
0
6
131
0.45
1.29
1.5
1.9
—
—
—
0
0
41
294
1.41
1.28
1.2
1.6
—
—
—
0
0
6
26
2.32
1.19
1.7
1.7
—
—
—
0
0
6
26
2.32
1.19
1.7
1.7
116.67
81.73
nmol/24h
—
6
26
22
141
1.57
1.18
1.1
2.0
0.00
0.52
g/l
1.53
17
129
37
501
0.73
1.11
4.7
12.3
121.03
125.98
g/l
1.11
37
489
8
41
1.96
1.09
1.0
1.1
—
—
—
0
0
7
32
2.20
1.08
1.7
1.6
—
—
—
0
0
16
97
1.66
1.07
1.0
1.1
—
—
—
0
0
160
1398
1.18
1.06
1.7
1.6
—
—
—
0
0
48
369
1.32
1.02
2.0
2.0
215.60
225.64
pmol/l
0.33
48
355
9
49
1.84
0.98
1.2
1.5
3.98
5.75
u/l
—
9
42
5
23
2.18
0.98
1.0
2.0
—
—
—
0
0
14
84
1.68
0.98
1.6
1.8
—
—
—
0
0
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
7
36
1.95
0.97
1.0
1.2
0.29
0.29
g/l
—
7
31
10
54
1.86
0.97
1.1
1.1
—
—
—
0
0
740
7589
0.86
0.95
4.2
4.5
2.74
2.86
mmol/l
3.95
718
7290
9
51
1.77
0.94
2.2
2.5
—
—
—
0
0
222
2010
1.14
0.92
1.9
2.3
—
—
—
0
0
19
126
1.52
0.91
1.1
1.1
—
1.46
—
0
10
146
1653
0.86
0.91
3.6
3.3
1.46
1.31
ug/l
0.38
138
1529
27
193
1.41
0.91
1.3
1.4
525.14
19.60
e6/l
0.64
22
141
14
219
0.63
0.91
1.6
1.9
—
—
—
0
0
5
101
0.49
0.90
1.2
1.3
190.90
191.11
pmol/l
—
5
101
8
42
1.91
0.88
1.4
1.6
—
—
—
0
0
8
42
1.91
0.88
1.4
1.6
—
—
—
0
0
8
42
1.91
0.88
1.4
1.6
—
—
—
0
0
6
31
1.94
0.84
2.0
1.6
—
—
—
0
0
25
342
0.72
0.84
5.2
13.8
25.76
24.30
mmol/l
0.69
25
335
27
197
1.38
0.83
1.4
1.4
461.64
1568.34
e6/l
0.56
22
151
16
105
1.53
0.82
1.0
1.1
—
—
—
0
0
16
105
1.53
0.82
1.8
1.5
—
—
—
0
0
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
659
6789
0.89
0.81
4.4
4.7
36.87
37.60
mmol/mol
1.56
642
6536
18
122
1.49
0.80
1.3
1.6
—
—
—
0
0
30
225
1.34
0.79
2.4
3.7
25.59
25.07
mmol/l
0.35
30
215
43
536
0.79
0.76
1.5
1.5
—
—
—
0
0
21
149
1.42
0.76
1.2
1.8
3.08
2.89
g/l
0.38
21
143
109
1242
0.86
0.76
2.2
2.3
—
—
—
0
0
9
53
1.71
0.75
1.2
1.1
—
—
—
0
0
201
1833
1.12
0.75
1.8
2.2
130.93
226.45
u/l
1.88
190
1758
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
38
1.85
0.73
1.1
1.2
—
—
—
0
0
15
100
1.51
0.73
1.9
3.0
0.94
1.49
ratio
—
5
47
7
40
1.76
0.71
4.0
3.8
1458.00
1577.83
mg
—
7
40
5
26
1.93
0.70
1.2
1.5
8.59
8.73
ug/l
—
5
26
16
111
1.45
0.66
1.1
1.3
—
—
—
0
0
16
111
1.45
0.66
1.1
1.3
—
—
—
0
0
12
78
1.55
0.65
1.1
1.1
—
—
—
0
0
738
7528
0.89
0.65
4.0
4.1
1.43
1.41
mmol/l
1.03
719
7219
14
95
1.48
0.64
1.1
1.1
—
—
—
0
0
5
30
1.67
0.61
2.0
1.6
—
—
—
0
0
22
165
1.34
0.61
1.1
1.0
1.24
2.59
eliau/ml
—
8
86
8
51
1.57
0.60
1.3
3.8
686.63
577.43
u/ml
—
8
51
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
21
157
1.35
0.59
1.2
1.8
7.27
7.04
g/l
0.24
21
151
21
157
1.35
0.59
1.2
1.8
4.26
3.64
g/l
1.21
21
151
21
157
1.35
0.59
1.2
1.8
4.87
4.35
g/l
0.46
21
150
232
2162
1.10
0.59
2.0
2.4
—
—
—
0
0
109
974
1.14
0.58
2.6
2.4
14.23
14.33
nmol/l
0.05
103
921
71
813
0.86
0.56
1.6
1.6
1095.91
1018.44
mu/l
0.20
61
686
64
552
1.17
0.56
3.1
10.1
1.22
1.29
mmol/l
0.38
64
541
9
60
1.50
0.54
1.2
1.1
1.10
1.06
ratio
—
9
54
14
191
0.73
0.51
1.4
1.3
—
—
—
0
0
9
65
1.39
0.50
1.0
1.8
—
—
—
0
0
18
136
1.33
0.49
1.2
1.8
11.00
10.30
g/l
0.36
18
129
208
2217
0.92
0.48
3.0
3.6
9.29
8.91
mmol/l
0.51
184
1977
39
328
1.20
0.47
2.1
1.8
—
—
—
0
0
5
83
0.60
0.46
12.8
6.0
11.60
8.06
%
—
5
83
94
1038
0.89
0.45
1.9
2.2
—
—
—
0
0
69
611
1.14
0.45
5.3
4.9
—
—
—
0
0
7
51
1.38
0.44
3.0
4.4
—
—
—
0
0
324
3099
1.07
0.44
1.9
1.9
1.44
1.45
mmol/l
0.06
291
2780
20
252
0.79
0.44
1.6
2.3
2.85
4.01
iu/l
—
8
113
685
6974
0.93
0.43
3.4
3.8
5.65
5.73
mmol/l
0.88
660
6597
15
113
1.33
0.43
2.1
3.2
30.27
34.80
mg/l
—
10
96
15
113
1.33
0.43
2.1
3.2
38.58
28.65
mg/l
—
10
96
745
7557
0.92
0.42
4.0
4.2
4.63
4.73
mmol/l
2.46
723
7281
39
333
1.18
0.41
1.3
1.3
—
—
—
0
0
5
34
1.47
0.40
1.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
0
18
0.00
0.40
0.0
2.1
—
—
—
0
0
41
353
1.17
0.40
2.2
3.5
134.46
135.74
g/l
0.16
41
343
8
61
1.31
0.39
1.4
1.2
14.00
7.56
mm/h
—
8
61
54
476
1.14
0.39
1.5
1.5
—
—
—
0
0
9
66
1.37
0.38
1.1
1.2
2.86
6.34
umol/l
—
9
58
17
135
1.26
0.35
1.2
1.2
—
—
—
0
0
42
478
0.87
0.34
1.8
1.9
—
—
—
0
0
617
6054
1.06
0.34
3.8
3.3
40.62
40.54
u/l
0.01
599
5862
66
597
1.11
0.33
2.1
2.4
4510.23
5358.00
u/l
0.09
15
251
19
228
0.83
0.29
3.2
3.2
24.63
24.71
mmol/l
0.07
19
220
19
157
1.21
0.29
1.2
1.2
1.33
5.33
u/ml
—
9
54
693
7022
0.94
0.29
4.6
4.9
1.58
1.77
mu/l
6.58
667
6706
46
411
1.13
0.29
2.7
4.6
2.17
23.98
ug/l
1.08
28
327
35
307
1.15
0.29
1.6
1.4
—
—
—
0
0
141
1490
0.94
0.28
1.5
1.9
1.36
1.41
%
0.53
122
1359
25
214
1.17
0.28
1.0
1.1
3.51
5.47
u/ml
—
10
106
162
1701
0.94
0.27
4.3
4.4
4.03
11.24
mg/mmol
3.46
108
1100
35
310
1.13
0.26
2.1
3.1
0.60
0.60
%
0.05
35
310
40
358
1.12
0.26
2.2
2.1
3.37
8.72
ug/l
2.89
34
328
122
1154
1.07
0.25
2.1
3.2
295.81
762.11
ng/l
1.19
53
696
66
609
1.09
0.25
1.4
1.4
19.01
19.88
iu/l
0.08
53
513
27
236
1.15
0.24
1.0
1.0
6.40
3.75
u/ml
0.26
13
128
25
286
0.87
0.24
1.5
1.6
58.38
57.11
ug/l
0.04
25
286
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
75
701
1.08
0.22
1.2
1.3
65.69
139.80
u/ml
1.76
26
283
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
45.35
—
0
13
0
14
0.00
0.20
0.0
1.1
—
10.43
—
0
14
34
375
0.90
0.20
1.6
1.7
—
—
—
0
0
24
212
1.14
0.19
1.0
1.0
0.29
0.34
u/ml
—
5
72
41
377
1.09
0.18
2.5
3.2
5.17
5.17
kpa
0.00
41
364
11
91
1.21
0.17
1.5
1.6
—
—
—
0
0
7
62
1.13
0.17
1.1
2.1
—
—
—
0
0
52
551
0.94
0.13
1.5
1.7
241.64
278.23
mu/l
0.99
47
507
16
143
1.12
0.11
1.1
1.1
—
—
—
0
0
52
547
0.95
0.11
1.0
1.1
1.56
1.49
g/l
0.98
52
547
13
115
1.13
0.10
1.5
1.1
—
—
—
0
0
53
555
0.95
0.10
1.1
1.1
0.88
0.90
g/l
0.37
53
555
5
44
1.14
0.10
3.6
1.9
1.68
1.78
nmol/l
—
5
36
16
146
1.10
0.08
1.1
1.2
129.88
135.25
iu/ml
—
5
41
8
76
1.05
0.07
1.9
1.5
0.41
0.48
e9/l
—
8
76
25
235
1.07
0.07
1.2
1.3
—
—
—
0
0
10
111
0.90
0.06
3.4
2.0
22.61
23.50
nmol/l
—
10
103
601
5983
1.01
0.05
3.9
4.1
14.79
14.47
pmol/l
2.67
564
5615
24
228
1.05
0.05
1.7
1.5
0.34
0.39
nmol/l
0.26
16
187
30
312
0.96
0.04
1.1
1.1
0.40
3.01
u/ml
—
10
171
28
272
1.03
0.02
1.0
1.1
3.01
1.95
u/ml
0.22
12
145
32
328
0.97
0.01
2.6
3.1
1.39
1.33
mmol/l
0.05
22
233
18
187
0.96
0.01
2.0
1.6
—
—
—
0
0
27
277
0.97
0.01
1.1
1.1
3.26
4.23
—
5
54
16
154
1.04
0.00
1.0
1.1
—
—
—
0
0
13
126
1.03
0.00
2.7
2.6
6.88
130.82
ug/min
—
5
77
16
162
0.99
0.00
1.1
1.2
2.20
5.82
u/ml
—
5
68
69
695
0.99
0.00
3.5
3.7
31.53
30.41
%
0.39
60
528
21
205
1.02
0.00
1.0
1.1
4.45
17.13
au/ml
—
8
81
21
215
0.98
0.00
2.7
6.8
1.90
1.64
%
0.24
21
197
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
6
61
0.98
-0.00
1.3
1.2
130.33
109.49
pmol/l
—
6
61
0
6
0.00
-0.00
0.0
3.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
67
0.89
-0.00
1.2
1.3
71.17
75.04
umol/l
—
6
67
7
73
0.96
-0.00
2.3
2.5
0.80
0.75
e9/l
—
7
73
5
54
0.93
-0.00
1.0
1.9
—
—
—
0
0
9
90
1.00
-0.00
1.1
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.8
—
6.98
—
0
9
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
28
280
1.00
-0.00
1.0
1.1
7.39
7.61
u/ml
0.02
13
171
0
5
0.00
-0.00
0.0
1.6
—
1338.20
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_L04AB02 – Infliximab
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).